Elbert Chin,Eric Brian Sjogren,Francisco Xavier Talamas,Javier de Vicente Fidalgo,Jim Li,Kenneth Albert Brameld,Ryan Craig Schoenfeld
申请号：
BRPI0916233
公开号：
BRPI0916233A2
申请日:
2009.07.15
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
Compounds having the formula I wherein R1, R2, R3, R4a, R4b, R4c, R5, R6, R9 and n are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
